Clinical Risk Prediction Model for Neoadjuvant Therapy in Resectable Esophageal Adenocarcinoma

• Published in: Journal of clinical gastroenterology Vol. 56; no. 2; p. 125
• Main Authors: Thota, Prashanthi N, Alkhayyat, Motasem, Gomez Cifuentes, Juan D, Haider, Mahnur, Bena, James, McMichael, John, Sohal, Davender P, Raja, Siva, Sanaka, Madhusudhan R
• Format: Journal Article
• Language: English
• Published: United States 01.02.2022
• Subjects: Adenocarcinoma - diagnosis; Aged; Barrett Esophagus - pathology; Cross-Sectional Studies; Esophageal Neoplasms - pathology; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Predictive Value of Tests

Clinical staging with endoscopic ultrasound (EUS) and positron emission tomography (PET) is used to identify esophageal adenocarcinoma (EAC) patients with locally advanced disease and therefore, benefit from neoadjuvant therapy. However, EUS is operator dependent and subject to interobserver variabi...